주식/증권 📈 긍정적

Replimune gains accelerated approval of Tudriqev for cutaneous melanoma

Seeking Alpha - Market News 08/06/2026 09:51:29 PM 85회

원문 기사 보기

관련 뉴스

Douglas Emmett tops most-shorted REITs above $2B; American Tower ranks lowest

Interactive Brokers' October revenue trades decline 4% Y/Y

Regal Rexnord Q3 2026 Earnings Preview

Blade Air Mobility Q3 Earnings Preview

뉴스 목록으로